Live Breaking News & Updates on Center Laboratories Inc
Stay updated with breaking news from Center laboratories inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AiViva Biopharma Appoints Jung-Chin (Rongjin) Lin, to the Board of Directors forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
COSTA MESA, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) AiViva Biopharma Inc., a clinical-stage biotechnology company developing innovative therapies to address major unmet medical needs, today announced the appointment of Mr. Jung-Chin (Rongjin) Lin to its board of directors. He is Honorary President of Center Laboratories, Inc. and Chairman of the Board of Lumosa Therapeutics Co., Ltd. and Glac Biotech Co., Ltd. He also serves as a Board member at Adimmune Corp. and BioGend Therapeutics Co., Ltd ....
Addentax Group Corp (ATXG) in Advanced Talks to Acquire Partial Stake in RMB 6B Recombinant Protein Drugs streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Addentax Group Corp. in Advanced Talks to Acquire Partial Stake in RMB 6 Billion-Valued Recombinant Protein Drugs and Antibody Drugs Bio-pharmaceutical Company, Shanghai Bao Pharmaceutical Company Limited tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
The remarkable results of strategic transformation of TOT, with a significant increase of 479% YoY in Operating Revenue, one-base, end-to-end ADC industrialization platform shows strong competitive finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.